INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-B-100 METABOLISM IN NORMOLIPEMIC SUBJECTS

被引:146
作者
DEMANT, T
BEDFORD, D
PACKARD, CJ
SHEPHERD, J
机构
[1] Institut fur Klinische Chemie, Klinikum Grosshadern
关键词
CATABOLISM; MODELING; KINETICS; SYNTHESIS; VERY LOW DENSITY LIPOPROTEIN;
D O I
10.1172/JCI115459
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study examined apolipoprotein (apo) B metabolism in normolipemic subjects homozygous for the apo E2 (n = 4), apo E3 (n = 5), or apo E4 (n = 5) phenotype. Radioiodinated very low density lipoprotein (VLDL1) (ultracentrifuge flotation rate [S(f)] 60-400) and VLDL2 (S(f) 20-60) were injected into volunteers and the conversion of apo B was followed through intermediate density lipoprotein (IDL) to low density lipoprotein (LDL). Subjects homozygous for E3 converted appproximately 50% of VLDL2 to LDL, the remainder being lost by direct catabolism. Those with the E2 phenotype produced less VLDL1 but converted more of it to VLDL2 (compared to E3 subjects). They displayed a characteristic dyslipidemia with the presence of slowly catabolized VLDL1 and VLDL2 remnants. LDL levels were low owing to increased direct catabolism of VLDL2 and IDL and a reduced efficiency of delipidation; only 25% of VLDL2 apo B was directed to LDL production. In contrast, E4 subjects converted more VLDL2 apo B to LDL than E3 subjects. About 70% of VLDL2 apo B was found in LDL; direct catabolism of VLDL and IDL was reduced as was the fractional catabolic rate of LDL (0.2 vs. 0.26 in E3 Subjects). These changes in the VLDL --> IDL --> LDL metabolic cascade can in part be explained by alterations in hepatic LDL receptors with E2 subjects having higher and E4 subjects lower activities than those in E3 homozygotes.
引用
收藏
页码:1490 / 1501
页数:12
相关论文
共 42 条
[1]   BILE-ACID METABOLISM IN FAMILIAL DYSBETALIPOPROTEINEMIA - STUDIES IN SUBJECTS WITH THE APOLIPOPROTEIN-E-2/2 PHENOTYPE [J].
ANGELIN, B ;
HOLMQUIST, L ;
LEIJD, B ;
EINARSSON, K .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (02) :143-149
[2]  
BERMAN M, 1978, J LIPID RES, V19, P38
[3]  
BERMAN M, 1974, US PHS PUBLICATION, V1703
[4]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+
[5]  
BRADLEY WA, 1984, J BIOL CHEM, V259, P4728
[6]  
BRENNINKMEIJER BJ, 1987, J LIPID RES, V28, P361
[7]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[8]  
DEMANT T, 1988, J LIPID RES, V29, P1603
[9]   ROLE OF APOLIPOPROTEIN-E IN THE LIPOLYTIC CONVERSION OF BETA-VERY- LOW-DENSITY LIPOPROTEINS TO LOW-DENSITY LIPOPROTEINS IN TYPE-III HYPERLIPOPROTEINEMIA [J].
EHNHOLM, C ;
MAHLEY, RW ;
CHAPPELL, DA ;
WEISGRABER, KH ;
LUDWIG, E ;
WITZTUM, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (17) :5566-5570
[10]   EFFECTS OF PROBUCOL ON PLASMA-LIPIDS AND LIPOPROTEINS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS WITH AND WITHOUT APOLIPOPROTEIN-E4 [J].
ETO, M ;
SATO, T ;
WATANABE, K ;
IWASHIMA, Y ;
MAKINO, I .
ATHEROSCLEROSIS, 1990, 84 (01) :49-53